SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-18-042823
Filing Date
2018-11-09
Accepted
2018-11-09 13:08:06
Documents
50
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 859398
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 8864
3 EXHIBIT 31 ex31.htm EX-31 13884
4 EXHIBIT 32 ex32.htm EX-32 6581
  Complete submission text file 0001140361-18-042823.txt   5681123

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bstc-20180930.xml EX-101.INS 1350358
6 XBRL TAXONOMY EXTENSION SCHEMA bstc-20180930.xsd EX-101.SCH 34827
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20180930_cal.xml EX-101.CAL 41127
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20180930_def.xml EX-101.DEF 226430
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20180930_lab.xml EX-101.LAB 511275
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20180930_pre.xml EX-101.PRE 347038
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 181172199
SIC: 2834 Pharmaceutical Preparations